Stock Analiz

Precision Optics Corporation, Inc. POCI

Biotechnology: Electromedical & Electrotherapeutic Apparatus · data as of November 13, 2026

$5.23Market cap $58M
Open the interactive analysis →

Precision Optics Corporation, Inc. (POCI) is a healthcare company listed in the US with a market value of about $58M. In fiscal year 2026 it had revenue of $32M and net income of -$4M, a net margin of -11.5%.

Its overall Stock Analiz score is 1.6 out of 5 (weak). The strongest part is future growth (4/5); the weakest is value (0/5).

Key numbers: 5-year revenue growth of 24% a year, a 5-year average ROIC of -15%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 67% below the current price.

About Precision Optics Corporation

Precision Optics Corporation is listed in the US and classified in biotechnology: electromedical & electrotherapeutic apparatus. Revenue went from $4M in 2015 to $32M in 2026, growth of about 20.9% a year. It was profitable in 0 of the last 10 years in our data. Its share count rose by 51% over three years (dilution for shareholders). It spends 3% of revenue on research and development.

Score: 1.6 / 5

Value0/5
Future growth4/5
Track record1/5
Financial health2/5
Shareholder returns1/5

Checks passed

  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving
  • Strong R&D investment or growth above 20%
  • 5-year revenue growth above 8% a year
  • More cash than debt, or low debt to equity
  • Liabilities below 60% of assets
  • Stock-based pay below 5% of revenue

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • 3-year free cash flow growth above 10% a year
  • 5-year EPS growth above 10% a year
  • 5-year average ROIC above 12%

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S1.8
P/B2.8
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-3.4%
Shareholder yield0.0%
Intrinsic value vs. price−67%

Growth and quality

Revenue growth (1 yr)65.2%
Revenue growth (5 yrs, per year)24.2%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-12.8%
ROIC (5-yr avg.)-14.6%
Profitable years (of last 10)0
Years paying a dividend—

Financials, last 10 years

Fiscal year2026202520242023202220212020201920182017
Revenue$32M$19M$19M$21M$16M$11M$10M$7M$4M$3M
Net income-$4M-$6M-$3M-$144613-$928416-$102835-$1M-$614871-$351390-$1M
Free cash flow-$2M-$4M-$3M-$97874-$1M-$29374-$711642-$1M$96209-$695153
EPS (diluted)$-0.43$-0.85$-0.49$-0.03$-0.18$-0.03$-0.33$-0.15$-0.12$-0.36
Net margin-11.5%-30.3%-15.4%-0.7%-5.9%-1.0%-14.4%-9.0%-8.7%-31.9%
ROIC-11.3%-30.8%-17.3%-3.4%-10.4%-20.5%-39.7%-14.3%-48.8%-141.8%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Is Precision Optics Corporation stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 67% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does Precision Optics Corporation pay a dividend?

Not currently.

Is Precision Optics Corporation a good stock to buy?

We do not give buy or sell advice. Precision Optics Corporation scores 1.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.